about
What we know about nonsteroidal anti-inflammatory drug hypersensitivityCurrent perspectives in NSAID-induced gastropathySeven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice?Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA)Nonsteroidal anti-inflammatory drug-induced reactions and desensitizationAdverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.Cyclic AMP and prostaglandin E in perfusates of rat hind paws during the development of adjuvant arthritis.Interaction between salicylate and two loop diureticsAsthma relieved by aspirin and by other cyclo-oxygenase inhibitorsSpecialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.Effect of some non-steroidal anti-inflammatory drugs on ouabain-induced arrhythmias in guinea-pigs.Restoration by ketoprofen of defective neutrophil granulocyte migration induced in guinea-pigs by plasma from cancer patients.Spontaneous activity in the trachea of dogs treated with indomethacin: an experimental model for aspirin-related asthma.Restriction of patching of bound concanavalin A after incorporation of arachidonic acid into the plasma membrane of virally transformed fibroblasts.Host-mediated resolution of inflammation in periodontal diseases.Increased diverticular complications with nonsteriodal anti-inflammatory drugs and other medications: a systematic review and meta-analysis.Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone.The biology, pathophysiology and control of eicosanoids in inflammation.Analgesic-antipyretic choices for children with asthma: a review of safety and risk of common preparations.Living history: Clark M. Blatteis.Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses.Effect of a single dose of a topical glucocorticoid and a cyclo-oxygenase inhibitor on allergen-induced changes in nasal reactivity.Flunixin fails to enhance cloxacillin in treatment of experimental staphylococcal mastitis in mice.Inhibition of prostaglandin biosynthesis by clidanac and related compounds: structural and conformational requirements for PG synthetase inhibition.Effects of indomethacin and dexamethasone on mechanical scratching-induced cutaneous barrier disruption in mice.Use of a Cyclooxygenase-2 Inhibitor Does Not Inhibit Platelet Activation or Growth Factor Release From Platelet-Rich Plasma.Individually controlled aspirin in the long-term treatment of patients with chronic arterial diseases.Na(+)-independent Active H(+) Extrusion and HCO(3)(-)/C1(-) Exchange Contribute to Cytoplasmic pH Regulation in the Human Platelet.Actions of indomethacin and prostaglandins on neuro-effector transmission in the dog trachea.Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.
P2860
Q26749250-06AA2974-2B8A-46B7-8011-A8B586436F38Q26827673-87580510-7DD1-4CA2-8129-4556DD9EEAE0Q28081823-4C6B2D01-E0F9-4241-92FA-BCC81EF36F18Q28193349-DF8456D2-97BE-41C4-A35A-B2D694B8BB81Q28209835-AE8F4935-E6CA-4462-94EF-DCEAA25D0A69Q33410375-5C7B5DBF-5196-4F59-AD86-656729CE5125Q33551426-E83F5BC9-D5E8-4845-A251-6E9983E9D2E7Q34518448-1D9107B5-1DE7-4608-9536-79A0E37C567CQ34717104-67E1F682-1C24-4873-9DC4-0D47762A612EQ35098090-2A280A17-0230-4C61-AA28-A254BA1C418AQ35755398-BA97B73D-80DA-47BA-AA6F-A2F9B9E7552AQ36091333-0A7AD5DA-2972-4AF2-9FDA-9A01D79392E2Q36128220-986918A0-BCEF-4469-A38B-64D16057EDC7Q36200763-DAC0B96B-AED2-4F47-BDD9-03C2927F83F2Q36362712-81A42DA1-C621-4467-921E-54F978BEDB4CQ38169787-803AD19D-568A-44DF-9F5A-1CA9BE8EDEA6Q39281655-1FC82407-D927-458B-A2EF-B5C9307DFECBQ39493756-9114E7E6-C16D-490C-8D4C-E6F3FA546FDDQ40214906-B84B2934-B700-4E1D-9A1A-B35725E07993Q40395732-DFA0E954-AA87-4A39-8B7F-0FB2A3640B9AQ42908395-A84FAD92-EC6E-408D-812D-87D79D330B03Q43919188-38557F21-C9C6-41BE-9A68-6B5E3099C8ECQ43922020-52384C08-AD3E-48FD-BE50-2D6EB70085D8Q46165295-0E2AACB2-1615-4E62-B4CD-9DCAD4411B75Q48691965-784688FA-FFC7-4FCA-BF87-FE69C8295401Q49789939-14142C4F-7C79-4844-8398-2B70873B8B3FQ51178116-834378D9-DD58-4966-ACA8-56E9589A9580Q54182823-0CA53777-6B1E-49CB-B2E0-D5BD8596CBCAQ54543542-0B7FB0FF-C579-4E47-A40C-BAB7218F17D0Q54916446-1B8A00CF-C0AD-4B07-9569-614B7AF847FE
P2860
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
The mode of action of aspirin and similar compounds.
@en
type
label
The mode of action of aspirin and similar compounds.
@en
prefLabel
The mode of action of aspirin and similar compounds.
@en
P1476
The mode of action of aspirin and similar compounds.
@en
P2093
P304
P356
10.1016/0091-6749(76)90181-0
P407
P577
1976-12-01T00:00:00Z